BIIB Financial Facts
Amortization of acquired intangible assets: 99.7MDiluted earnings per share attributable to Biogen Idec Inc.: 219.4M
See Full Income Statement
Accounts receivable, net: 1.47B
Accounts payable: 274M
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 7/23/24 *Est. | EPS Growth Rate | +7.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.8% | Revenue Growth Rate | -6.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/26/10  |
 |
Q310 | $1.35 | $1.23 | +$0.12 | N/A | N/A | N/A |  | | Details |
| 2/1/11 |
|
Q410 | $1.42 | $1.23 | +$0.19 | $1.22B | $1.17B | = | | | Details |
| 10/22/19 | |
Q319 | $9.17 | $8.27 | +$0.90 | $3.6B | $3.54B |  |
| | Details |
| 1/30/20 | |
Q419 | $8.34 | $8.00 | +$0.34 | $3.67B | $3.54B | = | | | Details |
| 4/21/11 |
|
Q111 | $1.43 | $1.41 | +$0.02 | $1.2M | $1.18B | = | | | Details |
| 1/29/15 |
|
Q414 | $4.09 | $3.78 | +$0.31 | $2.6B | $2.64B | |
| | Details |
| 7/23/14 |
|
Q214 | $3.49 | $2.81 | +$0.68 | $2.42B | $2.14B | |
| | Details |
| 7/21/16 |
|
Q216 | $5.21 | $4.68 | +$0.53 | $2.89B | $2.79B | = | | | Details |
